In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Neratinib Drug Master File in Korea (Neratinib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Neratinib. The MFDS reviews the Neratinib KDMF as part of the drug registration process and uses the information provided in the Neratinib KDMF to evaluate the safety and efficacy of the drug.
After submitting a Neratinib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Neratinib API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Neratinib suppliers with KDMF on PharmaCompass.